Time To Buy? Corinthian Colleges Inc (COCO), Hemispherx BioPharma Inc (HEB), And Amkor Technology Inc. (AMKR)

Posted by Nathan Alexander January 28, 2015 0 Comment 2333 views

New York, NY – GDP INSIDER  – 01/28/2015.

Corinthian Colleges Inc (NASDAQ:COCO) had nothing to celebrate as the post-secondary educator lost 1.59%, losing $0.0011 to close the day at $0.0679. The new price puts the stock 95.81% below its 52-week high and 13.17% above its 52-week low. Having opened at $0.06, the stock ended the session 4.46% above the opening price. Corinthian Colleges Inc (NASDAQ:COCO) traded in the range of $0.06 and $0.07 on a day that saw almost half of the daily average volume exchanging hands.

Is Corinthian Colleges Inc Going To Continue Selling Off Or Will Things Start Turning Around Soon? See What’s Next For COCO With A Free Trend Report

Hemispherx BioPharma, Inc (NYSEMKT:HEB) traded in the range of $0.21 and $0.23, having opened the session at $0.22. The specialty pharmaceutical company touched a new 52-week low of $0.21, but ended the session 4.35% down at $0.220, after drifting 2.22% away from the opening price. The closing stock price puts the $46.01 million market capped company, 4.76% above its 52-week low and 57.69% below its 52-week high. A smaller volume of just about 0.5 million exchanged hands compared with the average daily volume of about 1 million shares.

Hemispherx BioPharma, Inc (NYSEMKT:HEB) was awarded about $0.78 million by a federal court in Delaware after it prevailed against a company known as Cato Capital. The compensation covers attorney fees and other costs incurred by Hemispherx BioPharma because of the case.

Could Hemispherx BioPharma, Inc Continue To Fall Or Will We Find Support In The Near Future? See What Is In The Cards For HEB With A Complementary Trend Analysis.

Amkor Technology, Inc. (NASDAQ:AMKR) dropped 3.03%, shedding $0.21 to end the session at $6.73. Having opened at $6.82, the stock drifted 1.32% away from the opening price. The stock touched a session low of $6.54 and a high of $6.90 on a day that saw 1.49 million shares exchange hands compared with the average daily volume of less than 1 million shares. The closing price of $6.73 put Amkor Technology 34.06% above its 52-week low and 45.15% below its 52-week high.

Amkor Technology, Inc. (NASDAQ:AMKR), a semiconductor assembly and test provider, recently reached a litigation settlement with Tessera, Inc. (NASDAQ:TSRA). Amkor Technology will pay a total of $155 million over a period of four years to settle the claims brought against it by Tessera.

Is Rock Creek Pharmaceuticals Inc  Going To Turn It Around Or Will It Continue To Freefall? See Where RCPI Is Going Next With A Free Trend Analysis

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.

About Nathan Alexander

Nathan Alexander holds bachelor’s degrees in Journalism and European Studies from Boston University. Nathan reports round up the day’s business and financial market news and include keynote interviews with major business players and updates on Asian, European and US stock markets. He has interviewed heads of leading European banking institutions such as European Central Bank President Jean-Claude Trichet and HSBC Chairman Stephen Green, and CEOs from the business world including Microsoft founder Bill Gates, Virgin Chairman Sir Richard Branson and former Porsche President and CEO Dr Wendelin Wiedeking.

View all post by Nathan Alexander Visit author's website

Write Your Comment